Exercise of Options

RNS Number : 7448I
Hutchison China Meditech Limited
03 June 2014
 



 

 

 

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

 

 

Exercise of Options

 

 

London: Tuesday, 3 June 2014: Chi-Med announces that it has issued 768,182 ordinary shares of US$1.00 each (the "Shares") following the exercise of options by Mr Christian Hogg, Executive Director and Chief Executive Officer of Chi-Med, at an exercise price of GBP1.09 per share on 3 June 2014.  The options, granted in June 2005, will lapse after ten years.

 

Following the issue of the Shares, which are expected to be held as a long term investment by Mr Hogg, Mr Hogg is beneficially interested in 1,088,182 Shares, representing 2.06% of the current issued share capital of Chi-Med.

 

 

 

Ends

 

 

Enquiries

 

    Chi-Med

    Christian Hogg, CEO

Telephone:      +852 2121 8200



    Panmure Gordon (UK) Limited

    Richard Gray

    Andrew Potts

 

Telephone:      +44 20 7886 2500

 

 

 

    Citigate Dewe Rogerson

    Anthony Carlisle

    David Dible

Telephone:      +44 20 7638 9571

Mobile:             +44 7973 611 888

Mobile:             +44 7967 566 919

 

 

About Chi-Med

Chi-Med is a China-based healthcare group focused on researching, developing, manufacturing and selling pharmaceuticals and health-related consumer products.  Its China Healthcare Division manufactures, markets and distributes prescription and over-the-counter pharmaceuticals in China.  Its Drug R&D Division focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases.  Its emerging Consumer Products Division focuses on organic and natural consumer products in Asia.

 

Chi-Med (LSE:HCM) is majority owned by the multinational conglomerate Hutchison Whampoa Limited (SEHK:13).  For more information, please visit: www.chi-med.com.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEALKDEADLEFF
UK 100

Latest directors dealings